Filing Details

Accession Number:
0000950170-24-131606
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-27 17:09:59
Reporting Period:
2024-11-26
Accepted Time:
2024-11-27 17:09:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1782223 Pyxis Oncology Inc. PYXS Pharmaceutical Preparations (2834) 831160910
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796310 Ann Pamela Connealy C/O Pyxis Oncology, Inc.
321 Harrison Avenue, 11Th Fl. Suite 1
Boston MA 02118
Cfo & Coo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-26 5,450 $2.00 1,115,743 No 4 P Indirect By Trust
Common Stock Acquisiton 2024-11-26 83,400 $1.96 1,199,143 No 4 P Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 P Indirect By Spouse
Footnotes
  1. These shares are held directly by the Personal Def Ben Pln Trust, a revocable trust for which the Reporting Person and their spouse are the trustees.
  2. The price reported in column 4 is a weighted-average price.These shares were purchased in multiple transactions at prices ranging from $1.93 to $1.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.